Key result
siRNA knockdown cuts HCN4 expression ~62% and selectively upregulates NKX2-5 in cardiac progenitors.
Answers are grounded in this paper and cite their sources.
HCN4 knockdown in human iPSC-derived first heart field progenitors selectively upregulates NKX2-5 without affecting automaticity, suggesting a non-canonical role in early ventricular development.
Background: Hyperpolarization-activated cyclic nucleotide-gated channel 4 (HCN4), a key ion channel driving pacemaker automaticity, also serves as a marker of the first heart field (FHF). Emerging evidence from cancer and stem cell research indicates that HCN ion channels regulate proliferation and differentiation in non-excitable cells, underscoring their broader significance. However, the specific function of HCN4 in FHF progenitors remains unclear. Hypothesis: We hypothesize that HCN4 supports the expansion of FHF progenitors and contributes to early left ventricular development by modulating proliferation and differentiation. Methods: To model FHF differentiation in vitro, human iPSCs were directed toward ventricular cardiomyocytes (vCM). Removal of WNT inhibition on day (d) 5 marked the FHF progenitor stage. Small interfering RNA (siRNA) knockdown of HCN4 was performed at this stage to assess its role. Results: By d8, a 72-hour siRNA knockdown of HCN4 resulted in a significant downregulation of its expression level, decreasing from 11.2 ± 0.3 in the control to 4.3 ± 0.1 (p<0.001, n=3), indicating a 51.3% knockdown efficiency. Despite this, FHF or left ventricular marker expression (TBX5, HAND1, IRX4, CTNT) remained unchanged, except for NKX2-5, which was significantly upregulated upon HCN4 knockdown from 50.7 ± 0.6 in control to 60.3 ± 4.6 (p<0.001, n=3). Functionally, spontaneous beating rates remained unchanged between the HCN4 siRNA-treated group and control (50.0 ± 0.7 vs. 48.3 ± 2.7 bpm, n=3, p>0.05) indicating that HCN4 knockdown at d5 does not significantly affect automaticity of the FHF-derived vCM at d8. Western blot analysis further revealed that HCN4 protein was absent until d7, when progenitors have reached their specification into immature vCM. Conclusion: HCN4 is transcribed during FHF progenitor stages but is not detected at the protein level until d7. Its knockdown selectively upregulates NKX2-5 without broadly affecting other FHF markers, indicating a potential role in progenitor cell proliferation and/or commitment. The data warrants further investigation of non-canonical roles of HCN4 as a regulator of ventricular chamber development.
No takes yet. Share an insight, caveat, or question.
Butt et al. (2025) studied First heart field progenitor proliferation and differentiation. siRNA knockdown of HCN4 vs. control was evaluated on HCN4 expression level (p=<0.001). A 72-hour siRNA knockdown of HCN4 in human iPSC-derived first heart field progenitors significantly reduced its expression (4.3 vs 11.2, p<0.001) and selectively upregulated NKX2-5.
Synapse has enriched 10 related papers. Consider them for comparative context: